about
Novel techniques and targets in cardiovascular microRNA researchTargeting myocardial remodelling to develop novel therapies for heart failure: a position paper from the Working Group on Myocardial Function of the European Society of CardiologyNfat and miR-25 cooperate to reactivate the transcription factor Hand2 in heart failureA rapid and simple CYP2D6 genotyping assay--case study with the analgetic tramadolCardiac fibroblast-derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophyRole of miR-21 in the pathogenesis of atrial fibrosisMicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblastsAroclor 1254 modulates gene expression of nuclear transcription factors: implications for albumin gene transcription and protein synthesis in rat hepatocyte culturesSERCA2a gene therapy restores microRNA-1 expression in heart failure via an Akt/FoxO3A-dependent pathwayShort communication: asymmetric dimethylarginine impairs angiogenic progenitor cell function in patients with coronary artery disease through a microRNA-21-dependent mechanismInduction of nuclear transcription factors, cytochrome P450 monooxygenases, and glutathione S-transferase alpha gene expression in Aroclor 1254-treated rat hepatocyte cultures.Circulating microRNAs in patients with Shiga-Toxin-producing E. coli O104:H4 induced hemolytic uremic syndrome.Mechanisms underlying recoupling of eNOS by HMG-CoA reductase inhibition in a rat model of streptozotocin-induced diabetes mellitus.A phenotypic screen to identify hypertrophy-modulating microRNAs in primary cardiomyocytes.Cardiovascular importance of the microRNA-23/27/24 family.Circulating miR-423_5p fails as a biomarker for systemic ventricular function in adults after atrial repair for transposition of the great arteries.MicroRNA-24 antagonism prevents renal ischemia reperfusion injuryImpairment of endothelial progenitor cell function and vascularization capacity by aldosterone in mice and humans.Expression of xenobiotic metabolizing enzymes in different lung compartments of smokers and nonsmokersBreakthrough in cachexia treatment through a novel selective androgen receptor modulator?!Epigenetic modifications in cardiovascular disease.Tissue-specific effects of the nuclear factor kappaB subunit p50 on myocardial ischemia-reperfusion injury.The miRNA-212/132 family regulates both cardiac hypertrophy and cardiomyocyte autophagy.miRNAGE-34 induces cardiac damAGE.MicroRNAs in the broken heart.Activation of the miR-17 family and miR-21 during murine kidney ischemia-reperfusion injury.Circulating microRNAs as potential biomarkers of aerobic exercise capacity.A signature of circulating microRNAs differentiates takotsubo cardiomyopathy from acute myocardial infarctionEndothelial progenitor cells in pulmonary arterial hypertension.Regulation and function of miRNA-21 in health and disease.Biogenesis and regulation of cardiovascular microRNAs.MicroRNAs and vascular (dys)function.Identification of cardiovascular microRNA targetomes.MicroRNAs in hypertension: mechanisms and therapeutic targets.Microvesicles as novel biomarkers and therapeutic targets in transplantation medicine.Role of microRNAs in immunity and organ transplantation.Circulating and urinary microRNAs in kidney disease.Exosomes: new players in cell-cell communication.MicroRNAs in myocardial infarction.MicroRNAs in platelet physiology and pathology.
P50
Q26849658-5AEEE36B-BC0A-4018-BD84-7D917C3D0FF8Q27024879-B126EC07-5EE6-4BDF-95CC-2B338AEBBCDCQ28118235-1A7325A1-1747-4ED1-96C2-B891A884C891Q28185311-2ADA39D0-7A78-4029-B2DC-BF54284F7753Q28238421-2009F6AE-3672-4124-B155-E9B997A8AFC3Q28270271-589A0016-6D11-4F6F-96B7-B4A0857325ACQ28511032-2ABE47F4-F0D4-4744-A2CA-92180E2CBE1FQ28569551-F8FF8D4B-80CB-4900-B845-A2BB05C3BB71Q28854278-54A064EF-1C59-4848-9D74-93041B6BAA37Q28941773-C4B965BF-A30A-4446-A969-9722B7E93DB1Q31859852-FD3FEF58-8CA2-4222-8DDA-50FAC4D2B7C8Q33403833-DB5B0862-F189-47F0-A975-2DF63E154095Q33929661-390BFCEB-CC24-406E-8D83-1F766D6FE1A3Q33975776-1AD99827-8332-40E8-A0C2-2473EADC00E1Q34237674-75BFCF02-328D-402C-961B-5FB14BF62345Q34242118-30C4268B-4EBC-41E2-9555-7A890543953BQ34568822-41D3A1A9-83B1-4024-9CF6-5AA536FB17F5Q34981416-8FF6F848-216A-4632-A0DC-B6FEB398BAE8Q35173305-B308D902-5801-43C0-A01E-66BB5C01A96DQ35223985-4626EFAE-93F1-43B1-94BE-DE6D618C069BQ35898458-9A7D7B04-EE45-437C-A70C-F9DF95358BF0Q35916034-D3ABC759-9586-4A5B-94E0-6C6C1A7C328AQ36855897-482494DB-98DF-4FBC-9C14-9CF956C38927Q36973938-DF0E72F4-B8E4-4145-99C4-36A81BE0DA65Q36987247-6F915D0D-87D9-4DF7-B54F-9A73477284ABQ37139565-6B87DC3F-61DC-4B78-8A00-5281ECC3BDC5Q37576146-E14D9AEB-534D-4011-9EC7-4A3AF7525D7CQ37700310-47616236-3E20-4296-9A1C-C4876E59498DQ37777870-25DDE1D7-5FFF-494F-9B43-C3C192072378Q37895431-F3662C93-F8D0-4BC7-8258-6C9B897CE407Q37903568-95D1572E-4A4C-4BD9-AE95-C3347C9B862EQ37908517-10B37373-30B0-4273-9CD8-BAA7542A9258Q37925888-478143B6-EA57-49DB-A3BA-D30F7443A24EQ37952576-E026BBA1-9D9A-470F-BE33-9B49D9FA0FAEQ37955969-9F2936E2-1CBE-47A0-BA09-B53F2A676A06Q37966037-94316B3D-62A6-4ACE-BB0A-DAAF2AE4EF4DQ38009675-AB322A97-6F6F-4137-B5AD-B1C66AEA0760Q38035709-D0FAE5B4-6FF6-46AF-9BE7-C80A022465C4Q38074611-36B71893-64FB-4A6F-9EBC-3B1264AB0C9BQ38079980-66B547A7-F606-4AF2-B8D7-19BD39FBC598
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Thomas Thum
@ast
Thomas Thum
@en
Thomas Thum
@es
Thomas Thum
@nl
Thomas Thum
@sl
type
label
Thomas Thum
@ast
Thomas Thum
@en
Thomas Thum
@es
Thomas Thum
@nl
Thomas Thum
@sl
prefLabel
Thomas Thum
@ast
Thomas Thum
@en
Thomas Thum
@es
Thomas Thum
@nl
Thomas Thum
@sl
P214
P106
P21
P214
P31
P496
0000-0003-4360-1511
P735
P7859
viaf-15674172